Management of gestational diabetes in women with a concurrent severe acute respiratory syndrome coronavirus 2 infection, experience of a single center in Northern Italy.
Adult
Asymptomatic Diseases
COVID-19
/ complications
Cesarean Section
/ statistics & numerical data
Diabetes, Gestational
/ drug therapy
Female
Humans
Hypoglycemic Agents
/ therapeutic use
Infant, Newborn
Insulin
/ therapeutic use
Italy
Labor, Induced
/ statistics & numerical data
Pregnancy
Pregnancy Complications, Infectious
/ virology
Retrospective Studies
Coronavirus disease 2019
Diet
Gestational diabetes
Insulin
International Association of Diabetes and Pregnancy Study Groups
Management: Northern Italy
Pandemic
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
21
09
2020
revised:
12
10
2020
accepted:
22
10
2020
pubmed:
26
10
2020
medline:
2
3
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
In this study we describe the management of women with gestational diabetes (GD) and an ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the study is to evaluate whether coronavirus disease 2019 (COVID-19) can further complicate pregnancies, and if the protocol we usually use for GD pregnancies is also applicable to patients who have contracted a SARS-CoV-2 infection. This is a retrospective study analyzing all pregnant women with GD and concomitant COVID-19 admitted to our institution for antenatal care between March 1 and April 30, 2020. Among pregnant women with GD and a concomitant SARS-CoV-2 infection, the mean age was 32.9 (SD 5.6) years. Two patients (33%) were of white racial origin and four (67%) were of non-white racial origin. All patients were diagnosed with COVID-19 during the third trimester of pregnancy. Two women were asymptomatic and four were symptomatic. Only two (33.3%) women received treatment with insulin. None of the patients required intensive care or mechanical ventilation. No complications were found among the neonates. COVID-19 was not found to worsen the prognosis of patients with GD or of their offspring. Glycemic monitoring, diet therapy, and insulin, when needed, are sufficient for good metabolic control and favorable maternal and fetal outcomes.
Identifiants
pubmed: 33099770
doi: 10.1002/ijgo.13434
pmc: PMC9087777
doi:
Substances chimiques
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
335-338Informations de copyright
© 2020 International Federation of Gynecology and Obstetrics.
Références
BJOG. 2020 Aug;127(9):1116-1121
pubmed: 32339382
BMC Infect Dis. 2020 Aug 3;20(1):564
pubmed: 32746801
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Am J Obstet Gynecol. 2015 Feb;212(2):224.e1-9
pubmed: 25173183
Eur J Endocrinol. 2020 Aug;183(2):G49-G56
pubmed: 32454456
Acta Obstet Gynecol Scand. 2000 Aug;79(8):649-54
pubmed: 10949229
Acta Obstet Gynecol Scand. 2020 May;99(5):644-650
pubmed: 31898313
Int J Gynaecol Obstet. 2021 Mar;152(3):335-338
pubmed: 33099770
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296